Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
DDD00038894
ID: ALA5308177
Chembl Id: CHEMBL5308177
Max Phase: Preclinical
Molecular Formula: C19H19NO
Molecular Weight: 277.37
Associated Items:
ID: ALA5308177
Chembl Id: CHEMBL5308177
Max Phase: Preclinical
Molecular Formula: C19H19NO
Molecular Weight: 277.37
Associated Items:
Canonical SMILES: O=C(C1CC1c1ccccc1)N1CCc2ccccc2C1
Standard InChI: InChI=1S/C19H19NO/c21-19(18-12-17(18)15-7-2-1-3-8-15)20-11-10-14-6-4-5-9-16(14)13-20/h1-9,17-18H,10-13H2
Standard InChI Key: UCQKTQXYHINMRV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 277.37 | Molecular Weight (Monoisotopic): 277.1467 | AlogP: 3.38 | #Rotatable Bonds: 2 |
Polar Surface Area: 20.31 | Molecular Species: NEUTRAL | HBA: 1 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.38 | CX LogD: 3.38 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.82 | Np Likeness Score: -0.92 |
1. Izquierdo, M; Lin, D; De Rycker, M. (2023) RapidFire TcLAP Compounds Screening, [10.6019/CHEMBL5305021] |
Source(1):